Rapidly expanding knowledge on the role of the gut microbiome in health and disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 10, 2014, Pages 1981-1992

  Cenit M C ^a   Matzaraki, V ^a   Tigchelaar, E F ^a,b   Zhernakova, A ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

Autoimmunity; Meta omics; Microbiome; Next generation sequencing

Indexed keywords

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; DNA SEQUENCE; ENTEROPATHY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GASTROINTESTINAL DISEASE; GENETIC PREDISPOSITION; HOMEOSTASIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOREGULATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; METAGENOMICS; MICROBIOME; MUCOSAL IMMUNITY; NONHUMAN; OBESITY; REVIEW; RHEUMATOID ARTHRITIS;

EID: 84908328113     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.05.023     Document Type: Review

References (143)

1. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65. 10.1038/nature08821.
2. Human T., Project M. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214. 10.1038/nature11234.
3. Tremaroli V., Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249. 10.1038/nature11552.
4. Haiser H.J., Seim K.L., Balskus E.P., Turnbaugh P.J. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 2014, 5.
5. David L.a., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2013, 10.1038/nature12820.
6. Walker A.W., Ince J., Duncan S.H., Webster L.M., Holtrop G., Ze X., et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5:220-230. 10.1038/ismej.2010.118.
7. Zimmer J., Lange B., Frick J.-S., Sauer H., Zimmermann K., Schwiertz A., et al. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur. J. Clin. Nutr. 2012, 66:53-60. 10.1038/ejcn.2011.141.
8. Power S.E., O'Toole P.W., Stanton C., Ross R.P., Fitzgerald G.F. Intestinal microbiota, diet and health. Br. J. Nutr. 2014, 111:387-402. 10.1017/S0007114513002560.
9. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., Massart S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14691-14696. 10.1073/pnas.1005963107.
10. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180. 10.1038/nature09944.
11. Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.-Y., Keilbaugh S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108. 10.1126/science.1208344.
12. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11971-11975. 10.1073/pnas.1002601107.
13. Jakobsson H.E., Abrahamsson T.R., Jenmalm M.C., Harris K., Quince C., Jernberg C., et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section. Gut 2014, 63:559-566. 10.1136/gutjnl-2012-303249.
14. O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006, 7:688-693. 10.1038/sj.embor.7400731.
15. McFall-Ngai M. Adaptive immunity: care for the community. Nature 2007, 445:153. 10.1038/445153a.
16. van de Guchte M., Penaud S., Grimaldi C., Barbe V., Bryson K., Nicolas P., et al. The complete genome sequence of Lactobacillus bulgaricus reveals extensive and ongoing reductive evolution. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:9274-9279. 10.1073/pnas.0603024103.
17. Pleasants J.R. Rearing germfree cesarean-born rats, mice, and rabbits through weaning. Ann. N. Y. Acad. Sci. 1959, 78:116-126.
18. Amann R.I., Ludwig W., Schleifer K.H. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 1995, 59:143-169. 10.1016/j.jip.2007.09.009.
19. Mullis K., Faloona F., Scharf S., Saiki R., Horn G., Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb. Symp. Quant. Biol. 1986, 51(Pt 1):263-273. 10.1101/SQB.1986.051.01.032.
20. Rajilić-Stojanović M., Heilig H.G.H.J., Molenaar D., Kajander K., Surakka A., Smidt H., et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ. Microbiol. 2009, 11:1736-1751. 10.1111/j.1462-2920.2009.01900.x.
21. Zoetendal E.G., Rajilic-Stojanovic M., de Vos W.M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008, 57:1605-1615. 10.1136/gut.2007.133603.
22. Proctor L.M. The Human Microbiome Project in 2011 and beyond. Cell Host Microbe 2011, 10:287-291. 10.1016/j.chom.2011.10.001.
23. Sanger F., Coulson A.R. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J. Mol. Biol. 1975, 94:441-448. 10.1016/0022-2836(75)90213-2.
24. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U. S. A. 1977, 74:5463-5467. 10.1073/pnas.74.12.5463.
25. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigó R., Gingeras T.R., Margulies E.H., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816. 10.1038/nature05874.
26. Petrosino J.F., Highlander S., Luna R.A., Gibbs R.A., Versalovic J. Metagenomic pyrosequencing and microbial identification. Clin. Chem. 2009, 55:856-866. 10.1373/clinchem.2008.107565.
27. Chen K., Pachter L. Bioinformatics for whole-genome shotgun sequencing of microbial communities. PLoS Comput. Biol. 2005, 1:106-112. 10.1371/journal.pcbi.0010024.
28. Riesenfeld C.S., Schloss P.D., Handelsman J. Metagenomics: genomic analysis of microbial communities. Annu. Rev. Genet. 2004, 38:525-552. 10.1146/annurev.genet.38.072902.091216.
29. Margulies M., Egholm M., Altman W.E., Attiya S., Bader J.S., Bemben L.A., et al. Genome sequencing in open microfabricated high density picoliter reactors. Nat. Biotechnol. 2006, 437:376-380. 10.1038/nature03959.Copyright.
30. Mardis E.R. Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet. 2008, 9:387-402. 10.1146/annurev.genom.9.081307.164359.
31. Meyer M., Kircher M. Illumina sequencing library preparation for highly multiplexed target capture and sequencing. Cold Spring Harb. Protoc. 2010, 2010. (pdb.prot5448). 10.1101/pdb.prot5448.
32. Cole J.R., Wang Q., Cardenas E., Fish J., Chai B., Farris R.J., et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009, 37:D141-D145. 10.1093/nar/gkn879.
33. DeSantis T.Z., Hugenholtz P., Larsen N., Rojas M., Brodie E.L., Keller K., et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 2006, 72:5069-5072. 10.1128/AEM.03006-05.
34. Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2008, 36:D480-D484. 10.1093/nar/gkm882.
35. Overbeek R., Begley T., Butler R.M., Choudhuri J.V., Chuang H.-Y., Cohoon M., et al. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res. 2005, 33:5691-5702.
36. Langille M.G.I., Zaneveld J., Caporaso J.G., McDonald D., Knights D., Reyes J.a., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 2013, 31:814-821.
37. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359. 10.1126/science.1124234.
38. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484. 10.1038/nature07540.
39. Morgan X.C., Tickle T.L., Sokol H., Gevers D., Devaney K.L., Ward D.V., et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012, 13:R79.
40. Scher J.U., Sczesnak A., Longman R.S., Segata N., Ubeda C., Bielski C., et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013, 2:e01202. 10.7554/eLife.01202.
41. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60. 10.1038/nature11450.
42. Karlsson F.H., Tremaroli V., Nookaew I., Bergström G., Behre C.J., Fagerberg B., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013, 498:99-103. 10.1038/nature12198.
43. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500:541-546. 10.1038/nature12506.
44. Karlsson F.H., Fåk F., Nookaew I., Tremaroli V., Fagerberg B., Petranovic D., et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 2012, 3:1245. 10.1038/ncomms2266.
45. Wylie K.M., Weinstock G.M., Storch G.A. Emerging view of the human virome. Transl. Res. 2012, 160:283-290. 10.1016/j.trsl.2012.03.006.
46. Minot S., Sinha R., Chen J., Li H., Keilbaugh S.A., Wu G.D., et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 2011, 21:1616-1625. 10.1101/gr.122705.111.
47. Hofer U. Viral evolution: variation in the gut virome. Nat. Rev. Microbiol. 2013, 11:596. 10.1038/nrmicro3092.
48. Cui L., Morris A., Ghedin E. The human mycobiome in health and disease. Genome Med. 2013, 5:63. 10.1186/gm467.
49. Iliev I.D., Funari V.A., Taylor K.D., Nguyen Q., Reyes C.N., Strom S.P., et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012, 336:1314-1317. 10.1126/science.1221789.
50. van Baarlen P., Kleerebezem M., Wells J.M. Omics approaches to study host-microbiota interactions. Curr. Opin. Microbiol. 2013, 16:270-277. 10.1016/j.mib.2013.07.001.
51. Gosalbes M.J., Durbán A., Pignatelli M., Abellan J.J., Jiménez-Hernández N., Pérez-Cobas A.E., et al. Metatranscriptomic approach to analyze the functional human gut microbiota. PLoS One 2011, 6:e17447. 10.1371/journal.pone.0017447.
52. Verberkmoes N.C., Russell A.L., Shah M., Godzik A., Rosenquist M., Halfvarson J., et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J. 2009, 3:179-189. 10.1038/ismej.2008.108.
53. Marchesi J.R., Holmes E., Khan F., Kochhar S., Scanlan P., Shanahan F., et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res. 2007, 6:546-551. 10.1021/pr060470d.
54. Hooper L.V., Midtvedt T., Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002, 22:283-307. 10.1146/annurev.nutr.22.011602.092259.
55. Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G.P., et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 2004, 5:104-112. 10.1038/ni1018.
56. Kamada N., Seo S.-U., Chen G.Y., Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13:321-335. 10.1038/nri3430.
57. Fukuda S., Toh H., Hase K., Oshima K., Nakanishi Y., Yoshimura K., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547. 10.1038/nature09646.
58. Petersson J., Schreiber O., Hansson G.C., Gendler S.J., Velcich A., Lundberg J.O., et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G327-G333. 10.1152/ajpgi.00422.2010.
59. Cash H.L., Whitham C.V., Behrendt C.L., Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
60. Goodnow C.C., Sprent J., Fazekas de St Groth B., Vinuesa C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005, 435:590-597.
61. Westerberg L.S., Klein C., Snapper S.B. Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency-lessons learned from monogenic disorders in mice and men. Curr. Opin. Immunol. 2008, 20:646-654. 10.1016/j.coi.2008.10.004.
62. Lederberg J. Infectious history. Science 2000, 288:287-293. 10.1126/science.288.5464.287.
63. Smith K., McCoy K.D., Macpherson A.J. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 2007, 19:59-69. 10.1016/j.smim.2006.10.002.
64. Smythies L.E., Sellers M., Clements R.H., Mosteller-Barnum M., Meng G., Benjamin W.H., et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 2005, 115:66-75. 10.1172/JCI19229.
65. Smythies L.E., Shen R., Bimczok D., Novak L., Clements R.H., Eckhoff D.E., et al. Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation. J. Biol. Chem. 2010, 285:19593-19604. 10.1074/jbc.M109.069955.
66. Smith P.D., Janoff E.N., Mosteller-Barnum M., Merger M., Orenstein J.M., Kearney J.F., et al. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J. Immunol. Methods 1997, 202:1-11.
67. Smith P.D., Smythies L.E., Mosteller-Barnum M., Sibley D.A., Russell M.W., Merger M., et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 2001, 167:2651-2656.
68. Grimm M.C., Pavli P., Van de Pol E., Doe W.F. Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa-implications for pathogenesis. Clin. Exp. Immunol. 1995, 100:291-297.
69. Rogler G., Hausmann M., Vogl D., Aschenbrenner E., Andus T., Falk W., et al. Isolation and phenotypic characterization of colonic macrophages. Clin. Exp. Immunol. 1998, 112:205-215.
70. Liew F.Y., Xu D., Brint E.K., O'Neill L.A.J. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 2005, 5:446-458. 10.1038/nri1630.
71. Haverson K., Rehakova Z., Sinkora J., Sver L., Bailey M. Immune development in jejunal mucosa after colonization with selected commensal gut bacteria: a study in germ-free pigs. Vet. Immunol. Immunopathol. 2007, 119:243-253. 10.1016/j.vetimm.2007.05.022.
72. Williams A.M., Probert C.S.J., Stepankova R., Tlaskalova-Hogenova H., Phillips A., Bland P.W. Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse. Immunology 2006, 119:470-478. 10.1111/j.1365-2567.2006.02458.x.
73. Mitsuyama M., Ohara R., Amako K., Nomoto K., Yokokura T. Ontogeny of macrophage function to release superoxide anion in conventional and germfree mice. Infect. Immun. 1986, 52:236-239.
74. Mørland B., Midtvedt T. Phagocytosis, peritoneal influx, and enzyme activities in peritoneal macrophages from germfree, conventional, and ex-germfree mice. Infect. Immun. 1984, 44:750-752.
75. Mikkelsen H.B., Garbarsch C., Tranum-Jensen J., Thuneberg L. Macrophages in the small intestinal muscularis externa of embryos, newborn and adult germ-free mice. J. Mol. Histol. 2004, 35:377-387.
76. Ohkubo T., Tsuda M., Tamura M., Yamamura M. Impaired superoxide production in peripheral blood neutrophils of germ-free rats. Scand. J. Immunol. 1990, 32:727-729.
77. Ohkubo T., Tsuda M., Suzuki S., El Borai N., Yamamura M. Peripheral blood neutrophils of germ-free rats modified by in vivo granulocyte-colony-stimulating factor and exposure to natural environment. Scand. J. Immunol. 1999, 49:73-77.
78. Walker J.A., Barlow J.L., McKenzie A.N.J. Innate lymphoid cells-how did we miss them?. Nat. Rev. Immunol. 2013, 13:75-87. 10.1038/nri3349.
79. Sonnenberg G.F., Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012, 37:601-610. 10.1016/j.immuni.2012.10.003.
80. Cherrier M., Ohnmacht C., Cording S., Eberl G. Development and function of intestinal innate lymphoid cells. Curr. Opin. Immunol. 2012, 24:277-283. 10.1016/j.coi.2012.03.011.
81. Satoh-Takayama N., Vosshenrich C.A.J., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970. 10.1016/j.immuni.2008.11.001.
82. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 2009, 10:83-91. 10.1038/ni.1684.
83. Mortha A., Chudnovskiy A., Hashimoto D., Bogunovic M., Spencer S.P., Belkaid Y., et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 2014, 343:1249288. 10.1126/science.1249288.
84. Khoury K.A., Floch M.H., Hersh T. Small intestinal mucosal cell proliferation and bacterial flora in the conventionalization of the germfree mouse. J. Exp. Med. 1969, 130:659-670. 10.1084/jem.130.3.659.
85. Reikvam D.H., Erofeev A., Sandvik A., Grcic V., Jahnsen F.L., Gaustad P., et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One 2011, 6:e17996. 10.1371/journal.pone.0017996.
86. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 2010, 10:159-169. 10.1038/nri2710.
87. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977. 10.1126/science.1206095.
88. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341. 10.1126/science.1198469.
89. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498. 10.1016/j.cell.2009.09.033.
90. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4615-4622. (Suppl.). 10.1073/pnas.1000082107.
91. Wu H.-J., Ivanov I.I., Darce J., Hattori K., Shima T., Umesaki Y., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827. 10.1016/j.immuni.2010.06.001.
92. Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474:307-317. 10.1038/nature10209.
93. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 2008, 8:458-466. 10.1038/nri2340.
94. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606. 10.1038/35079114.
95. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cézard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603. 10.1038/35079107.
96. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 2003, 278:5509-5512. 10.1074/jbc.C200673200.
97. Bevins C.L., Salzman N.H. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 2011, 9:356-368. 10.1038/nrmicro2546.
98. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schäffeler E., Schlee M., et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004, 53:1658-1664. 10.1136/gut.2003.032805.
99. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18129-18134. 10.1073/pnas.0505256102.
100. Petnicki-Ocwieja T., Hrncir T., Liu Y.-J., Biswas A., Hudcovic T., Tlaskalova-Hogenova H., et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15813-15818. 10.1073/pnas.0907722106.
101. Couturier-Maillard A., Secher T., Rehman A., Normand S., De Arcangelis A., Haesler R., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 2013, 123:700-711. 10.1172/JCI62236.
102. Rehman A., Sina C., Gavrilova O., Häsler R., Ott S., Baines J.F., et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011, 60:1354-1362. 10.1136/gut.2010.216259.
103. McGovern D.P.B., Jones M.R., Taylor K.D., Marciante K., Yan X., Dubinsky M., et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum. Mol. Genet. 2010, 19:3468-3476. 10.1093/hmg/ddq248.
104. Rausch P., Rehman A., Künzel S., Häsler R., Ott S.J., Schreiber S., et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:19030-19035. 10.1073/pnas.1106408108.
105. Quince C., Lundin E.E., Andreasson A.N., Greco D., Rafter J., Talley N.J., et al. The impact of Crohn's disease genes on healthy human gut microbiota: a pilot study. Gut 2013, 62:952-954. 10.1136/gutjnl-2012-304214.
106. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55:205-211. 10.1136/gut.2005.073817.
107. Sokol H., Lay C., Seksik P., Tannock G.W. Analysis of bacterial bowel communities of IBD patients: what has it revealed?. Inflamm. Bowel Dis. 2008, 14:858-867. 10.1002/ibd.20392.
108. Ott S.J., Kühbacher T., Musfeldt M., Rosenstiel P., Hellmig S., Rehman A., et al. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand. J. Gastroenterol. 2008, 43:831-841. 10.1080/00365520801935434.
109. Sokol H., Seksik P., Rigottier-Gois L., Lay C., Lepage P., Podglajen I., et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel Dis. 2006, 12:106-111. 10.1097/01.MIB.0000200323.38139.c6.
110. Sokol H., Seksik P., Furet J.P., Firmesse O., Nion-Larmurier I., Beaugerie L., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 2009, 15:1183-1189. 10.1002/ibd.20903.
111. Machiels K., Joossens M., Sabino J., De Preter V., Arijs I., Eeckhaut V., et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2013, 1-9. 10.1136/gutjnl-2013-304833.
112. Gevers D., Kugathasan S., Denson L.A., Vázquez-Baeza Y., Van Treuren W., Ren B., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014, 15:382-392. 10.1016/j.chom.2014.02.005.
113. Serrano N.C., Millan P., Páez M.-C. Non-HLA associations with autoimmune diseases. Autoimmun. Rev. 2006, 5:209-214. 10.1016/j.autrev.2005.06.009.
114. Kyvik K.O., Green A., Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ 1995, 311:913-917.
115. Brusca S.B., Abramson S.B., Scher J.U. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr. Opin. Rheumatol. 2013, 1-7. 10.1097/BOR.0000000000000008.
116. Scher J.U., Abramson S.B. The microbiome and rheumatoid arthritis. Nat. Rev. Rheumatol. 2011, 10.1038/nrrheum.2011.121.
117. Vaahtovuo J., Munukka E., Korkeamäki M., Luukkainen R., Toivanen P. Fecal microbiota in early rheumatoid arthritis. J. Rheumatol. 2008, 35:1500-1505.
118. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455:1109-1113. 10.1038/nature07336.
119. Bach J.-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 2002, 347:911-920. 10.1056/NEJMra020100.
120. Ochoa-Repáraz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Foureau D.M., Haque-Begum S., et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2009, 183:6041-6050. 10.4049/jimmunol.0900747.
121. Ochoa-Repáraz J., Mielcarz D.W., Haque-Begum S., Kasper L.H. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 2010, 1:103-108. 10.4161/gmic.1.2.11515.
122. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023. 10.1038/4441022a.
123. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11070-11075. 10.1073/pnas.0504978102.
124. Kalliomäki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 2008, 87:534-538.
125. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031. 10.1038/nature05414.
126. Turnbaugh P.J., Bäckhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3:213-223. 10.1016/j.chom.2008.02.015.
127. Ridaura V.K., Faith J.J., Rey F.E., Cheng J., Duncan A.E., Kau A.L., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013, 341:1241214. 10.1126/science.1241214.
128. Koeth R.A., Wang Z., Levison B.S., Buffa J.A., Org E., Sheehy B.T., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 2013, 19:576-585. 10.1038/nm.3145.
129. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185. 10.1038/nature10809.
130. Smeekens S.P., Huttenhower C., Riza A., van de Veerdonk F.L., Zeeuwen P.L.J.M., Schalkwijk J., et al. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses. J. Innate Immun. 2014, 6:253-262. 10.1159/000351912.
131. Lozupone C.A., Li M., Campbell T.B., Flores S.C., Linderman D., Gebert M.J., et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe 2013, 14:329-339. 10.1016/j.chom.2013.08.006.
132. Elopre L., Rodriguez M. Fecal microbiota therapy for recurrent Clostridium difficile infection in HIV-infected persons. Ann. Intern. Med. 2013, 158:779-780. 10.7326/0003-4819-158-10-201305210-00021.
133. Markle J.G.M., Frank D.N., Mortin-Toth S., Robertson C.E., Feazel L.M., Rolle-Kampczyk U., et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013, 339:1084-1088. 10.1126/science.1233521.
134. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231. 10.1126/science.1179721.
135. Caricilli A.M., Picardi P.K., de Abreu L.L., Ueno M., Prada P.O., Ropelle E.R., et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol. 2011, 9:e1001212. 10.1371/journal.pbio.1001212.
136. Garrett W.S., Gallini C.A., Yatsunenko T., Michaud M., DuBois A., Delaney M.L., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010, 8:292-300. 10.1016/j.chom.2010.08.004.
137. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757. 10.1016/j.cell.2011.04.022.
138. Stone M., Fortin P.R., Pacheco-Tena C., Inman R.D. Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. J. Rheumatol. 2003, 30:2112-2122.
139. Abdollahi-Roodsaz S., Joosten L.A.B., Koenders M.I., Devesa I., Roelofs M.F., Radstake T.R.D.J., et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 2008, 118:205-216. 10.1172/JCI32639.
140. Smits L.P., Bouter K.E.C., de Vos W.M., Borody T.J., Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013, 145:946-953. 10.1053/j.gastro.2013.08.058.
141. Aroniadis O.C., Brandt L.J. Fecal microbiota transplantation: past, present and future. Curr. Opin. Gastroenterol. 2013, 29:79-84. 10.1097/MOG.0b013e32835a4b3e.
142. de Vos W.M., Nieuwdorp M. Genomics: a gut prediction. Nature 2013, 498:48-49. 10.1038/nature12251.
143. Khoruts A., Dicksved J., Jansson J.K., Sadowsky M.J. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea 2010, 44:354-360. 10.1097/MCG.0b013e3181c87e02.